Jump to ContentJump to Main Navigation
Show Summary Details

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor-in-Chief: Llerena, Adrián

Editorial Board Member: Benjeddou, Mongi / Chen, Bing / Dahl, Marja-Liisa / Devinsky, Ferdinand / Hirata, Rosario D. C. / Hubacek, Jaroslav A. / Ingelman-Sundberg, Magnus / Maitland-van der Zee, Anke-Hilse / Manolopoulos, Vangelis G. / Marc, Janja / Melichar, Bohuslav / Meyer, Urs A. / Nair, Sujit / Nofziger, Charity / Peiro, Ana / Sadee, Wolfgang / Salazar, Luis A. / Simmaco, Maurizio / Turpeinen, Miia / Schaik, Ron / Shin, Jae-Gook / Visvikis-Siest, Sophie / Zanger, Ulrich M.


SCImago Journal Rank (SJR) 2015: 0.447
Source Normalized Impact per Paper (SNIP) 2015: 0.524
Impact per Publication (IPP) 2015: 1.329

99,00 € / $149.00 / £75.00*

Online
ISSN
2363-8915
See all formats and pricing



Select Volume and Issue

Issues

30,00 € / $42.00 / £23.00

Get Access to Full Text

NEUROCHEMICAL PROFILE OF ELTOPRAZINE

J. Schipper, / M.Th.M. Tulp, / H. Sijbesma,

Citation Information: Drug Metabolism and Drug Interactions. Volume 8, Issue 1-2, Pages 85–114, ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: 10.1515/DMDI.1990.8.1-2.85, May 2011

Publication History

Published Online:
2011-05-11

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Veronica Ghiglieri, Desiree Mineo, Anna Vannelli, Fabrizio Cacace, Maria Mancini, Valentina Pendolino, Francesco Napolitano, Anna di Maio, Manuela Mellone, Jennifer Stanic, Elisabetta Tronci, Camino Fidalgo, Roberto Stancampiano, Manolo Carta, Paolo Calabresi, Fabrizio Gardoni, Alessandro Usiello, and Barbara Picconi
Neurobiology of Disease, 2015
[2]
[3]
Dave J. Hayes and Andrew J. Greenshaw
Neuroscience & Biobehavioral Reviews, 2011, Volume 35, Number 6, Page 1419
[4]
R. M. M. De Almeida, M. M. Rosa, D. M. Santos, D. M. Saft, Q. Benini, and K. A. Miczek
Psychopharmacology, 2006, Volume 185, Number 4, Page 441
[5]
Roger M. Pinder and Joop H. Wieringa
Medicinal Research Reviews, 1993, Volume 13, Number 3, Page 259
[6]
Anton J. M. Loonen
Pharmaceutisch Weekblad Scientific Edition, 1992, Volume 14, Number 4, Page 206
[7]
B. Olivier, M. Th. M. Tulp, and J. Mos
Human Psychopharmacology: Clinical and Experimental, 1991, Volume 6, Number S1, Page S73
[8]
Beatriz Rocha, Monique Rigo, Georges Di Scala, Guy Sandner, and Daniel Hoyer
European Journal of Pharmacology, 1994, Volume 262, Number 1-2, Page 125
[9]
Jan Mos, Berend Olivier, Marjo Poth, Ruud Van Oorschot, and Hans Van Aken
European Journal of Pharmacology, 1993, Volume 238, Number 2-3, Page 411
[10]
Joan McGuirk, Richard Muscat, and Paul Willner
Pharmacology Biochemistry and Behavior, 1992, Volume 41, Number 4, Page 801
[11]
Jan Mos, Hans H.M. van Aken, Ruud van Oorschot, and Berend Olivier
European Neuropsychopharmacology, 1996, Volume 6, Number 1, Page 1
[12]
J. Moriarty, B. Schmitz, M. R. Trimble, and P. De Koning
Human Psychopharmacology: Clinical and Experimental, 1994, Volume 9, Number 4, Page 253
[13]
A NEWMAN-TANCREDI, C CONTE, C CHAPUT, L VERRIÈLE, and M.J MILLAN
Neuropharmacology, 1997, Volume 36, Number 4-5, Page 451
[14]
Sharon B Wigal and Sophie Duong
Expert Opinion on Drug Metabolism & Toxicology, 2011, Volume 7, Number 6, Page 775

Comments (0)

Please log in or register to comment.